An open-label, randomized, phase 2 Study of R-CHOP plus enzastaurin versus R-CHOP in the first-line treatment of patients with intermediate- or high-riskdiffuse large B-cell lymphoma.
AUTHORS
Hainsworth
JD ,
Arrowsmith
ER ,
McCleod
M ,
Hsi
ED ,
Hamid
O ,
Shi
P ,
Lin
BK ,
Fayad
LE ,
. Leukemia & lymphoma. 2015 5 8; (). 1-11
- PMID: 25956042 [PubMed].
ABSTRACT
Tags: Alumni Publications 2015